| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 07/30/2026 | ±4.3% | -6.0% | under-priced |
| 04/23/2026 | ±2.8% | -0.4% | over-priced |
| 10/30/2025 | ±2.9% | +2.6% | over-priced |
| 08/07/2025 | ±2.4% | -1.8% | over-priced |
| 04/24/2025 | ±3.1% | -0.7% | over-priced |
| 10/31/2024 | ±2.4% | -0.3% | over-priced |
| 07/25/2024 | ±1.5% | +1.0% | over-priced |
| 04/25/2024 | ±1.8% | -0.6% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q2 FY2026 | — | $1.1B | $180M |
| Q1 FY2026 | — | $1.0B | $150M |
| Q3 FY2025 | — | $1.1B | $183M |
| Q2 FY2025 | — | $1.1B | $175M |
Erie Indemnity Co (ERIE) reports in 72 days, with the next report estimated for 11/23/2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 1.7% on average — the market has systematically over-priced ERIE's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 10.1%. QuantLogix's live 5-factor engine currently reads ERIE as a buy at 61/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →